SCHEMBL6504790

SCHEMBL6504790

COc1ccccc1-c1ccc(CC(=O)Cc2ccc(-c3ccccc3OC)cc2)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC13A5 Q86YT5 1/20 0.54
PPARG P37231 1/20 0.53
PPARA Q07869 1/20 0.53
MEN1 O00255 1/20 0.51
KMT2A Q03164 1/20 0.51
KDM4E B2RXH2 1/20 0.50
ALDH1A1 P00352 1/20 0.50
HPGD P15428 1/20 0.50
HSD17B10 Q99714 1/20 0.50
TDP1 Q9NUW8 1/20 0.50
MME P08473 1/20 0.50
MMEL1 Q495T6 1/20 0.50
GRM2 Q14416 1/20 0.48
PTPRC P08575 1/20 0.47
PTPN1 P18031 1/20 0.47
WNT3A P56704 1/20 0.47
PTGER4 P35408 1/20 0.47
ITGA4 P13612 3/20 0.46
ITGB7 P26010 1/20 0.46
PTGDR2 Q9Y5Y4 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4207640 0.89 SLC13A5 (0.60) SLC13A5PPARGPPARAMEN1KMT2A
SCHEMBL7146926 0.89 SLC13A5 (0.53) SLC13A5PPARGPPARAMEN1KMT2A
SCHEMBL26659934 0.82 FYN (0.56) SLC13A5PPARGPPARAKDM4EALDH1A1
SCHEMBL3677264 0.80 FFAR1 (0.66) SLC13A5PPARGPPARAMMEMMEL1
SCHEMBL20022996 0.79 PPARG (0.50) SLC13A5PPARGPPARAMEN1KMT2A
SCHEMBL11673547 0.79 NAAA (0.50) SLC13A5PPARGPPARAMMEMMEL1
SCHEMBL12646406 0.78 SLC13A5 (0.56) SLC13A5PPARGPPARAKDM4EALDH1A1
SCHEMBL11267011 0.78 KDM4E (0.53) MEN1KMT2AKDM4EALDH1A1PTPN1
SCHEMBL19043338 0.78 SLC13A5 (0.49) SLC13A5PPARGPPARAKDM4EALDH1A1
SCHEMBL21246919 0.77 PTPRC (0.51) SLC13A5PPARGPPARAALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6858739-B2 Indole and benzimidazole 15-lipoxygenase inhibitors WARNER-LAMBERT COMPANY (US) 2005-02-22 US disclosed
US-20040038943-A1 Indole and benzimidazole 15-lipoxygenase inhibitors CONNOR DAVID THOMAS (US) 2004-02-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040038943-A1 Indole and benzimidazole 15-lipoxygenase inhibitors ALOX15, ALOX5, ALOX12 SLC13A5 681/4885PPARG 1084/4885PPARA 921/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.